Iter Investments — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.
AI & Machine LearningBiotechDeep TechHealthtechMental HealthTampa, US
Jacqueline Lee Salm(Executive Officer)Jackie von Salm(Co-Founder & Chief Scientific Officer)inChris Witowski(Co-Founder & CEO)Scott Rairigh(EVP, Corporate Development)Magali Haas(Chief Medical Officer)
Co-investorsBonaventure Equity, LLC
Reset Pharma is a CNS-focused pharmaceutical company developing psilocybin and related psychedelics for the treatment of mental illness in patients with life-threatening diseases.
BiotechDigital HealthHealthtechMental HealthNew York, US
John Andreadis(Executive Officer, Director)Jan-Anders Karlsson(Executive Officer, Director)Philip Taub(Director)Tim Schlidt(Director)
Co-investorsPsyMed Ventures
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)
Co-investorsBonaventure Equity, LLCHatteras Venture PartnersMission BiocapitalService Provider CapitalRoute 66 VenturesSante Health Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.